Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes

Background: Many people with diabetes continue to smoke despite being at high risk of cardiovascular disease. We examined the impact of a pay-for-performance incentive in the United Kingdom introduced in 2004 as part of the new general practitioner contract to improve support for smoking cessation and to reduce the prevalence of smoking among people with chronic diseases such as diabetes. Methods: We performed a population-based longitudinal study of the recorded delivery of cessation advice and the prevalence of smoking using electronic records of patients with diabetes obtained from participating general practices. The survey was carried out in an ethnically diverse part of southwest London before (June–October 2003) and after (November 2005–January 2006) the introduction of a pay-for-performance incentive. Results: Significantly more patients with diabetes had their smoking status ever recorded in 2005 than in 2003 (98.8% v. 90.0%, p <0.001). The proportion of patients with documented smoking cessation advice also increased significantly over this period, from 48.0% to 83.5% (p < 0.001). The prevalence of smoking decreased significantly from 20.0% to 16.2% (p < 0.001). The reduction over the study period was lower among women (adjusted odds ratio 0.71, 95% confidence interval 0.53–0.95) but was not significantly different in the most and least affluent groups. In 2005, smoking rates continued to differ significantly with age (10.6%–25.1%), sex (women, 11.5%; men, 20.6%) and ethnic background (4.9%–24.9%). Interpretation: The introduction of a pay-for-performance incentive in the United Kingdom increased the provision of support for smoking cessation and was associated with a reduction in smoking prevalence among patients with diabetes in primary health care settings. Health care planners in other countries may wish to consider introducing similar incentive schemes for primary care physicians.

[1]  L. Anderson Index of Multiple Deprivation , 2008 .

[2]  Nih State-of-the-Science Panel National Institutes of Health State-of-the-Science Conference Statement: Tobacco Use: Prevention, Cessation, and Control , 2006, Annals of Internal Medicine.

[3]  Kathleen N Lohr,et al.  Systematic Review: Smoking Cessation Intervention Strategies for Adults and Adults in Special Populations , 2006, Annals of Internal Medicine.

[4]  Laura Petersen,et al.  Does Pay-for-Performance Improve the Quality of Health Care? , 2006, Annals of Internal Medicine.

[5]  K. Reiter,et al.  Pay-for-performance in publicly financed healthcare: some international experience and considerations for Canada. , 2006, HealthcarePapers.

[6]  P. Nilsson,et al.  The gap between guidelines and reality: Type 2 diabetes in a national diabetes register 1996–2003 , 2005, Diabetic medicine : a journal of the British Diabetic Association.

[7]  T. Marteau,et al.  General practitioners' and family physicians' negative beliefs and attitudes towards discussing smoking cessation with patients: a systematic review. , 2005, Addiction.

[8]  W. Abraham Preventing cardiovascular events in patients with diabetes mellitus. , 2004, The American journal of medicine.

[9]  S. Saydah,et al.  Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.

[10]  A. Majeed,et al.  Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registers , 2003, BMJ : British Medical Journal.

[11]  Won S. Choi,et al.  Impact of patient characteristics on physician's smoking cessation strategies. , 2003, Preventive medicine.

[12]  M. Gulliford,et al.  Cigarette smoking, health status, socio-economic status and access to health care in diabetes mellitus: a cross-sectional survey , 2003, BMC health services research.

[13]  T. Coleman,et al.  Discussion of NRT and other antismoking interventions in UK general practitioners' routine consultations. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[14]  J. de Irala,et al.  Intervention study for smoking cessation in diabetic patients: a randomized controlled trial in both clinical and primary care settings. , 2000, Diabetes care.

[15]  R. Holman,et al.  Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) , 1998, BMJ.

[16]  N. Chaturvedi,et al.  Socioeconomic gradient in morbidity and mortality in people with diabetes: cohort study findings from the Whitehall study and the WHO multinational study of vascular disease in diabetes , 1998, BMJ.

[17]  E. Ford,et al.  Trends in Cigarette Smoking and Physicians' Advice to Quit Smoking Among People with Diabetes in the U.S. , 1995, Diabetes Care.

[18]  P. McNamara,et al.  Morbidity and Mortality in Diabetics In the Framingham Population: Sixteen Year Follow-up Study , 1974, Diabetes.

[19]  P. J. Huber The behavior of maximum likelihood estimates under nonstandard conditions , 1967 .